128 related articles for article (PubMed ID: 38056240)
1. Canagliflozin reduces thyroid cancer cells migration in vitro by inhibiting CXCL8 and CCL2: An additional anti-tumor effect of the drug.
Coperchini F; Greco A; Croce L; Pignatti P; Muzza M; Petrosino E; Teliti M; Magri F; Rotondi M
Biomed Pharmacother; 2024 Jan; 170():115974. PubMed ID: 38056240
[TBL] [Abstract][Full Text] [Related]
2. Vitamin D Reduces Thyroid Cancer Cells Migration Independently From the Modulation of CCL2 and CXCL8 Chemokines Secretion.
Coperchini F; Greco A; Croce L; Petrosino E; Grillini B; Magri F; Chiovato L; Rotondi M
Front Endocrinol (Lausanne); 2022; 13():876397. PubMed ID: 35498406
[TBL] [Abstract][Full Text] [Related]
3. The AMPK-activator AICAR in thyroid cancer: effects on CXCL8 secretion and on CXCL8-induced neoplastic cell migration.
Awwad O; Coperchini F; Pignatti P; Denegri M; Massara S; Croce L; Di Buduo CA; Abbonante V; Balduini A; Chiovato L; Rotondi M
J Endocrinol Invest; 2018 Nov; 41(11):1275-1282. PubMed ID: 29546654
[TBL] [Abstract][Full Text] [Related]
4. PFOA, PFHxA and C6O4 differently modulate the expression of CXCL8 in normal thyroid cells and in thyroid cancer cell lines.
Coperchini F; De Marco G; Croce L; Denegri M; Greco A; Magri F; Tonacchera M; Imbriani M; Rotondi M; Chiovato L
Environ Sci Pollut Res Int; 2023 May; 30(23):63522-63534. PubMed ID: 37052835
[TBL] [Abstract][Full Text] [Related]
5. The BRAF-inhibitor PLX4720 inhibits CXCL8 secretion in BRAFV600E mutated and normal thyroid cells: a further anti-cancer effect of BRAF-inhibitors.
Coperchini F; Croce L; Denegri M; Awwad O; Ngnitejeu ST; Muzza M; Capelli V; Latrofa F; Persani L; Chiovato L; Rotondi M
Sci Rep; 2019 Mar; 9(1):4390. PubMed ID: 30867499
[TBL] [Abstract][Full Text] [Related]
6. Tumor-derived CXCL8 signaling augments stroma-derived CCL2-promoted proliferation and CXCL12-mediated invasion of PTEN-deficient prostate cancer cells.
Maxwell PJ; Neisen J; Messenger J; Waugh DJ
Oncotarget; 2014 Jul; 5(13):4895-908. PubMed ID: 24970800
[TBL] [Abstract][Full Text] [Related]
7. The anti-cancer effects of phenformin in thyroid cancer cell lines and in normal thyrocytes.
Coperchini F; Croce L; Denegri M; Awwad O; Ngnitejeu ST; Magri F; Chiovato L; Rotondi M
Oncotarget; 2019 Nov; 10(60):6432-6443. PubMed ID: 31741708
[TBL] [Abstract][Full Text] [Related]
8. Do PFCAs drive the establishment of thyroid cancer microenvironment? Effects of C6O4, PFOA and PFHxA exposure in two models of human thyroid cells in primary culture.
Coperchini F; Greco A; Croce L; Teliti M; Calì B; Chytiris S; Magri F; Rotondi M
Environ Int; 2024 May; 187():108717. PubMed ID: 38728818
[TBL] [Abstract][Full Text] [Related]
9. The oncolytic virus dl922-947 reduces IL-8/CXCL8 and MCP-1/CCL2 expression and impairs angiogenesis and macrophage infiltration in anaplastic thyroid carcinoma.
Passaro C; Borriello F; Vastolo V; Di Somma S; Scamardella E; Gigantino V; Franco R; Marone G; Portella G
Oncotarget; 2016 Jan; 7(2):1500-15. PubMed ID: 26625205
[TBL] [Abstract][Full Text] [Related]
10. Normal human thyroid cells, BCPAP, and TPC-1 thyroid tumor cell lines display different profile in both basal and TNF-α-induced CXCL8 secretion.
Coperchini F; Pignatti P; Leporati P; Carbone A; Croce L; Magri F; Chiovato L; Rotondi M
Endocrine; 2016 Oct; 54(1):123-128. PubMed ID: 26450713
[TBL] [Abstract][Full Text] [Related]
11. Effect of Interferon-γ on the Basal and the TNFα-Stimulated Secretion of CXCL8 in Thyroid Cancer Cell Lines Bearing Either the RET/PTC Rearrangement Or the BRAF V600e Mutation.
Rotondi M; Coperchini F; Awwad O; Pignatti P; Di Buduo CA; Abbonante V; Magri F; Balduini A; Chiovato L
Mediators Inflamm; 2016; 2016():8512417. PubMed ID: 27555670
[TBL] [Abstract][Full Text] [Related]
12. Tumor-Stroma-Inflammation Networks Promote Pro-metastatic Chemokines and Aggressiveness Characteristics in Triple-Negative Breast Cancer.
Liubomirski Y; Lerrer S; Meshel T; Rubinstein-Achiasaf L; Morein D; Wiemann S; Körner C; Ben-Baruch A
Front Immunol; 2019; 10():757. PubMed ID: 31031757
[TBL] [Abstract][Full Text] [Related]
13. Interferon-γ and tumor necrosis factor-α sustain secretion of specific CXC chemokines in human thyrocytes: a first step toward a differentiation between autoimmune and tumor-related inflammation?
Rotondi M; Coperchini F; Pignatti P; Sideri R; Groppelli G; Leporati P; La Manna L; Magri F; Mariotti S; Chiovato L
J Clin Endocrinol Metab; 2013 Jan; 98(1):308-13. PubMed ID: 23118425
[TBL] [Abstract][Full Text] [Related]
14. Monocyte-astrocyte networks and the regulation of chemokine secretion in neurocysticercosis.
Uddin J; Garcia HH; Gilman RH; Gonzalez AE; Friedland JS
J Immunol; 2005 Sep; 175(5):3273-81. PubMed ID: 16116219
[TBL] [Abstract][Full Text] [Related]
15. Metformin reverts the secretion of CXCL8 induced by TNF-α in primary cultures of human thyroid cells: an additional indirect anti-tumor effect of the drug.
Rotondi M; Coperchini F; Pignatti P; Magri F; Chiovato L
J Clin Endocrinol Metab; 2015 Mar; 100(3):E427-32. PubMed ID: 25590211
[TBL] [Abstract][Full Text] [Related]
16. Interplay between thyroid cancer cells and macrophages: effects on IL-32 mediated cell death and thyroid cancer cell migration.
Sloot YJE; Rabold K; Ulas T; De Graaf DM; Heinhuis B; Händler K; Schultze JL; Netea MG; Smit JWA; Joosten LAB; Netea-Maier RT
Cell Oncol (Dordr); 2019 Oct; 42(5):691-703. PubMed ID: 31201646
[TBL] [Abstract][Full Text] [Related]
17. Assessment of CCL2 and CXCL8 chemokines in serum, bronchoalveolar lavage fluid and lung tissue samples from dogs affected with canine idiopathic pulmonary fibrosis.
Roels E; Krafft E; Farnir F; Holopainen S; Laurila HP; Rajamäki MM; Day MJ; Antoine N; Pirottin D; Clercx C
Vet J; 2015 Oct; 206(1):75-82. PubMed ID: 26231926
[TBL] [Abstract][Full Text] [Related]
18. Regulation of the inflammatory profile of stromal cells in human breast cancer: prominent roles for TNF-α and the NF-κB pathway.
Katanov C; Lerrer S; Liubomirski Y; Leider-Trejo L; Meshel T; Bar J; Feniger-Barish R; Kamer I; Soria-Artzi G; Kahani H; Banerjee D; Ben-Baruch A
Stem Cell Res Ther; 2015 May; 6(1):87. PubMed ID: 25928089
[TBL] [Abstract][Full Text] [Related]
19. Unfractionated Heparin Selectively Modulates the Expression of CXCL8, CCL2 and CCL5 in Endometrial Carcinoma Cells.
Doster A; Schwarzig U; Zygmunt M; Rom J; Schütz F; Fluhr H
Anticancer Res; 2016 Apr; 36(4):1535-44. PubMed ID: 27069129
[TBL] [Abstract][Full Text] [Related]
20. CC chemokine ligand 2 and CXC chemokine ligand 8 as neutrophil chemoattractant factors in canine idiopathic polyarthritis.
Murakami K; Maeda S; Yonezawa T; Matsuki N
Vet Immunol Immunopathol; 2016 Dec; 182():52-58. PubMed ID: 27863550
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]